TEPH: Telaglenastat Efficacy in Pulmonary Hypertension

NCT07223528 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Hypertension

Interventions

DRUG: Telaglenastat

Sponsor

Chan, Stephen, MD, PhD

Collaborators

[object Object]